Sabitlenmiş Tweet
1/ 🔬🧫Tumoral lactic acid bacteria can rewire tumor metabolism and drive cancer treatment response. Our @cancercell paper is finally out #openaccess online! 🦠🔬
tinyurl.com/56puk8bx
English
Lauren E. Colbert, MD MSCR
1.4K posts
Lauren E. Colbert, MD MSCR
@colbertle
physician-scientist, GYN brachytherapist @mdandersonnews. #biostats nerd. we study tumor and vaginal #Microbiome, #HPV. Proud girl mom.
Houston, TX Katılım Eylül 2014
2K Takip Edilen1.9K Takipçiler
@DrMariSea @RRS_RadRes @ACKoongMDPhD 😆 Colbert Lab will be there! @DalissaNF already put together a mandatory abstract workshop to make sure everyone submits
English
@colbertle you’re in luck then because @RRS_RadRes is in PR next year and @ACKoongMDPhD allegedly maybe possibly could have said he’s giving everyone the week off.
English
New policy: only attending conferences in places where you need to match your sun hat to your suit. #tmcs2024
English
Lauren E. Colbert, MD MSCR retweetledi
Do you want to use patient-derived organoids to model cervical cancer? Our group (study led by staff scientist Rui Wang!) did the hard troubleshooting for you and published it as an easy-to-follow protocol 🤗
star-protocols.cell.com/protocols/3754
English
Whoever gets to work with @goharmanzar will be one lucky person!! 🍀 She is a one of a kind scientist, teacher and mentor! #postdocjobs #Postdocs
English
English
My son highlighted the @MDAndersonNews #bootwalk when sharing fun family moments during his family 🧑🧑🧒 & friends 👯♂️presentation 🤗
@sumeethj, Christopher, & I can’t wait to do the 👢 walk again this year!
🙏🏻 to anyone that considers donating to help us #endcancer
English
Look at those RT waterfall plots 🤩 Great work by @AnnKloppMD and @adam_grippin !!
Ramez Kouzy, MD@RKouzyMD
Proud of my co-resident @adam_grippin for presenting the IMMUNOCERV Phase II Trial results at #ASTRO24! Exciting insights on how PDS0101 vaccine w/ CRT could contribute to the care of patients with advanced cervical cancer. @AnnKloppMD @colbertle @ChelseaPinnix @MDAndersonNews
English
Lauren E. Colbert, MD MSCR retweetledi
Remarkable innovation by another stellar resident @MDAndersonNews @BenjaminSchrank in @wenjiang_nano lab to enhance anti-tumor immunity through a novel macrophage targeting ADC!! @ACKoongMDPhD @ChelseaPinnix
English
Lauren E. Colbert, MD MSCR retweetledi
Brilliant presentation by @MDAndersonNews #RadOnc PGY5 resident @BenjaminSchrank today. This is the FIRST antibody-drug conjugate specifically designed to enhance immune activation against cancer. LET’S GOOOO! @wenjiang_nano @BettyKimLab @ACKoongMDPhD #ASTRO24
UT MD Anderson@UTMDAnderson
Dr. Benjamin Schrank explains his recent research on a first-in-class antibody-drug conjugate that is designed to trigger an immune response, as a complementary strategy to radiation therapy. Read more: bit.ly/3XXRmWW @BenjaminSchrank #ASTRO24 #EndCancer
English
Lauren E. Colbert, MD MSCR retweetledi
@MDAndersonNews @BenjaminSchrank @BenjaminSchrank is without a doubt one of the very best physician scientist trainee I have ever encountered. Quadruple threat: great scientist, leadership skills, gifted educator and super kind/humble. Truly exceptional. He’s also on the job market. So proud!
English
Lauren E. Colbert, MD MSCR retweetledi
Dr. Benjamin Schrank explains his recent research on a first-in-class antibody-drug conjugate that is designed to trigger an immune response, as a complementary strategy to radiation therapy.
Read more: bit.ly/3XXRmWW @BenjaminSchrank #ASTRO24 #EndCancer
English
Well this is a depressing clinical trials session at #ASTRO24… protons aren’t better in prostate cancer, concurrent IO isn’t better than SOC in SCLC or H&N cancer (but we kinda expected this). Sounds to me like we need MORE BASIC SCIENCE RESEARCH with biomarkers 🤓
English
Lauren E. Colbert, MD MSCR retweetledi
⭐️PGY3 @dr_p_carriere @MDAndersonNews #radonc co-resident crushed his talk on pt-reported functional decline post-AS, RP, EBRT w/o ADT, or LDR at #ASTRO2024 @ASTRO_org
Great job, Patrick!!! 👏👏👏
& Excellent mentorship from @KHoffmanMD 💪
English
Fantastic work by one of our PGY5 aspiring physician scientists! @Vince_BernPag is the real deal and a total phys sci superstar - it’s amazing to see this project develop from the beginning to these great discoveries and looking forward to how his work will impact patients
Chelsea C Pinnix MD PhD@ChelseaPinnix
Congrats to @MDAndersonNews #RadOnc PGY5 Holman pathway resident @Vince_BernPag on this compelling work exploring molecular processes related to response to RT via longitudinal tumor biopsies for pts with pancreatic cancer before & after SBRT.@ACKoongMDPhD @PrajnanDasMD #ASTRO24
English
Lauren E. Colbert, MD MSCR retweetledi
Persister cells after neoadjuvant treatment for pancreatic cancer are enriched in genes involved in #ferroptosis and #cuproptosis. Fantastic translational study by @Vince_BernPag from @MDAndersonNews. #ASTRO24 #endcancer #radonc
English
Lauren E. Colbert, MD MSCR retweetledi
What's new in enhancing gynecologic outcomes?
Meet our experts, Drs. Lauren Colbert and Ann Klopp, in booth 741 to learn more at 11 a.m. EDT. @colbertle @AnnKloppMD (3/4) #ASTRO24 #EndCancer
English
We still have work to do #neurosurgeons! Met a young academic neurosurgeon. When I asked about his research he said he has #K08 from NIH and started to teach me how I can apply…I’m like…Dude I have multiple #R01s…but didn’t. #DontJudgeABookByItsCovers
English
Lauren E. Colbert, MD MSCR retweetledi
A woman dies from #CervicalCancer every 2 minutes. These deaths are typically preventable! Let’s use the tools we have and save lives 💉 🔬🔪☢️🧪
@clau_carvajal_ #ASTRO24 @ASTRO_org @pipcosper @sophia_kamran @somera_mx
English
Lauren E. Colbert, MD MSCR retweetledi
A first-in-class antibody-drug conjugate works by targeting protein CD47, which helps immune cells activate and engulf cancer cells. The drug triggers an adaptive immune response to help eliminate the tumor. Learn more about the research, which Dr. Ben Schrank will present at #ASTRO24: bit.ly/3XXRmWW #EndCancer
English
Way to go @dr_p_carriere!
Urology Times@UrologyTimes
1 in 3 men to receive RP or EBRT for treatment of localized #ProstateCancer reported “moderate to big problems” with sexual function 10 years later, according to a new longterm study at #ASTRO24. Read more longterm functional outcomes from #CEASAR here: urologytimes.com/view/how-do-pr…
English